Cutting-edge nanotechnology to cure seromas
Seromas affect millions of patients globally
Seromas are wound-like fluid-filled cavities that occur after a variety of surgeries
Especially breast cancer surgery and tissue reconstruction patients are highly affected with seroma rates of 50%-80%. In the best case, affected patients only suffer from pain, limited mobility, and multiple doctor visits. Many patients, however, go through infections, additional surgery, and a delay in cancer therapy delay.
There are more than 3 million patients who suffer from a seroma and its consequences every year.
Our nanoparticles make seromas heal
Our solution features anti-inflammatory, tissue regenerative, and antimicrobial properties
At ETH Zurich and Empa St. Gallen, we have developed mixed metal oxide nanoparticles that stimulate regeneration in close collaboration with leading surgeons in the field. Applied into seromas, they reduce the dead space of the cavity, mimic human enzymes to reduce inflammation, and kill microbes upon contact.
Due to these unique properties, they can also be utilized to support the healing of a wide variety of other wounds and complications.
Our mission
Seromas and poorly healing wounds in general are a massive burden for patients, health care systems, and the economy. An aging society, the rise of diabetes and antibiotic resistances are bound to increase the problem. The last decades have brought little improvement in the field – most products focus on structure restoration or contain expensive biologics.
We believe it's time for a change.
After decades of research, nanotechnology is mature enough to step into the breach and disrupt the wound care market.
TEAM
We are an interdisciplinary team with backgrounds in nanoscience, engineering, life science, and business administration. Our product is developed in close collaboration with surgeons and leading medical experts.
COLLABORATORS AND ADVISORS
We collaborate with leading scientific and clinical institutions, such as ETH Zurich, Empa, the University Hospital Bern, and the University Hospital Zurich.
WHERE TO MEET US
Mo., 05. Okt.Bern
JÜRG H. SCHNETZER
Former Executive Director Swissmedic
Regulatory advisor
PROF. DR. INGE KATRIN HERRMANN
Translational Science Expert
ETH Zurich | Empa
Scientific advisor
PROF. DR. MIHAI CONSTANTINESCU
Plastic Surgeon
University Hospital Bern
Clinical advisor
MICHAEL STUCKY
Successful Life Science Enterpreneur
Business advisor
SUPPORT
GET IN TOUCH WITH US
